Brevan Howard Capital Management’s Pediatrix Medical MD Stock Holding History

Brevan Howard Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$205K	Sell	9,583 -17,576	-65%	-$366K	﹤0.01%	1883
2025 Q4	$581K	Sell	27,159 -2,833	-9%	-$58.1K	0.01%	1026
2025 Q3	$502K	Sell	29,992 -55,304	-65%	-$829K	﹤0.01%	1293
2025 Q2	$1.22M	Buy	+85,296	New	+$1.17M	0.01%	968
2024 Q4	–	Sell	-27,620	Closed	-$320K	–	1280
2024 Q3	$320K	Sell	27,620 -9,277	-25%	-$87.5K	﹤0.01%	828
2024 Q2	$279K	Buy	+36,897	New	+$305K	﹤0.01%	802
2024 Q1	–	Sell	-14,364	Closed	-$134K	–	1211
2023 Q4	$134K	Buy	+14,364	New	+$149K	﹤0.01%	927

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Brevan Howard Capital Management's MD Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Pediatrix Medical (MD) stake by 65% in Q1 2026, selling an estimated $366K and leaving 9,583 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

Brevan Howard Capital Management first reported a position in MD in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.22M in Q2 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

Brevan Howard Capital Management held 9,583 shares of Pediatrix Medical worth $205K as of Q1 2026.
Brevan Howard Capital Management sold 17,576 Pediatrix Medical shares in Q1 2026, an estimated $366K.
Pediatrix Medical made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1883 holding.
Brevan Howard Capital Management first reported a position in Pediatrix Medical in Q4 2023 and has held it in 7 quarters since.
Brevan Howard Capital Management's Pediatrix Medical position peaked at $1.22M in Q2 2025.
296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.